As of 10:52am ET
| +0.0301 / +1.24%|
The 2 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 14.50, with a high estimate of 20.00 and a low estimate of 9.00. The median estimate represents a +491.81% increase from the last price of 2.45.
The current consensus among 3 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.